Episil-Precision Inc.
TWSE:3016.TW
31.3 (TWD) • At close May 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,107.47 | 4,236.502 | 5,899.587 | 5,043.332 | 4,039.18 | 3,854.729 | 4,524.026 | 3,342.938 | 2,790.99 | 779.272 | 881.528 | 823.454 | 748.276 | 825.82 | 912.186 | 477.35 |
| Cost of Revenue
| 3,725.465 | 3,741.029 | 4,797.706 | 4,316.899 | 3,795.221 | 3,609.323 | 3,754.038 | 2,879.425 | 2,538.946 | 729.102 | 787.066 | 738.7 | 685.993 | 718.891 | 750.462 | 500.556 |
| Gross Profit
| 382.005 | 495.473 | 1,101.881 | 726.433 | 243.959 | 245.406 | 769.988 | 463.513 | 252.044 | 50.17 | 94.462 | 84.754 | 62.283 | 106.929 | 161.724 | -23.206 |
| Gross Profit Ratio
| 0.093 | 0.117 | 0.187 | 0.144 | 0.06 | 0.064 | 0.17 | 0.139 | 0.09 | 0.064 | 0.107 | 0.103 | 0.083 | 0.129 | 0.177 | -0.049 |
| Reseach & Development Expenses
| 72.144 | 88.345 | 70.091 | 68.52 | 61.344 | 61.66 | 77.708 | 76.615 | 54.071 | 14.498 | 16.376 | 15.504 | 19.615 | 16.086 | 24.281 | 28.335 |
| General & Administrative Expenses
| 189.507 | 176.75 | 185.626 | 139.392 | 124.798 | 126.316 | 132.9 | 110.173 | 115.654 | 67.512 | 59.246 | 57.748 | 58.705 | 61.591 | 61.15 | 49.442 |
| Selling & Marketing Expenses
| 47.394 | 47.409 | 61.365 | 54.408 | 46.343 | 52.677 | 59.9 | 55.326 | 54.853 | 20.247 | 21.127 | 23.147 | 24.69 | 25.227 | 25.483 | 16.389 |
| SG&A
| 236.901 | 224.159 | 246.991 | 193.8 | 171.141 | 178.993 | 192.8 | 165.499 | 170.507 | 87.759 | 80.373 | 80.895 | 83.395 | 86.818 | 86.633 | 65.831 |
| Other Expenses
| 0 | 0 | 77.031 | 24.264 | 23.661 | 21.912 | 37.865 | 3.407 | 31.51 | 47.398 | 28.511 | 0.569 | 15.347 | 16.723 | 30.507 | 33.089 |
| Operating Expenses
| 309.045 | 311.262 | 317.082 | 262.32 | 232.485 | 240.653 | 270.508 | 242.114 | 224.578 | 102.257 | 96.749 | 96.399 | 103.01 | 102.904 | 110.914 | 94.166 |
| Operating Income
| 72.96 | 182.969 | 875.888 | 493.333 | 38.977 | 26.665 | 499.48 | 221.399 | 27.466 | -52.087 | -2.287 | -11.645 | -40.727 | 4.025 | 50.81 | -117.372 |
| Operating Income Ratio
| 0.018 | 0.043 | 0.148 | 0.098 | 0.01 | 0.007 | 0.11 | 0.066 | 0.01 | -0.067 | -0.003 | -0.014 | -0.054 | 0.005 | 0.056 | -0.246 |
| Total Other Income Expenses Net
| 244.951 | 22.646 | 69.866 | 16.556 | -19.118 | -16.184 | 29.817 | -9.393 | 20.843 | 8.371 | 20.143 | -14.741 | -5.853 | 19.186 | 30.066 | 43.512 |
| Income Before Tax
| 317.911 | 205.615 | 854.665 | 480.669 | 19.859 | 10.481 | 529.297 | 212.006 | 48.309 | -14.771 | 17.856 | -26.386 | -47.828 | 15.524 | 80.876 | -73.86 |
| Income Before Tax Ratio
| 0.077 | 0.049 | 0.145 | 0.095 | 0.005 | 0.003 | 0.117 | 0.063 | 0.017 | -0.019 | 0.02 | -0.032 | -0.064 | 0.019 | 0.089 | -0.155 |
| Income Tax Expense
| 53.303 | 41.576 | 173.394 | 100.139 | -5.834 | 0.003 | 99.178 | 31.696 | 28.246 | -0.055 | 1.254 | 0.841 | 0.246 | 1.523 | 4.559 | 0.027 |
| Net Income
| 264.608 | 164.039 | 681.271 | 380.53 | 25.693 | 10.478 | 430.119 | 180.31 | 20.063 | -14.716 | 16.602 | -27.227 | -48.074 | 14.001 | 76.317 | -73.887 |
| Net Income Ratio
| 0.064 | 0.039 | 0.115 | 0.075 | 0.006 | 0.003 | 0.095 | 0.054 | 0.007 | -0.019 | 0.019 | -0.033 | -0.064 | 0.017 | 0.084 | -0.155 |
| EPS
| 0.93 | 0.57 | 2.38 | 1.35 | 0.093 | 0.038 | 1.57 | 0.74 | 0.08 | -0.099 | 0.18 | -0.29 | -0.51 | 0.15 | 0.81 | -0.81 |
| EPS Diluted
| 0.93 | 0.57 | 2.36 | 1.35 | 0.093 | 0.038 | 1.56 | 0.74 | 0.08 | -0.099 | 0.18 | -0.29 | -0.51 | 0.15 | 0.8 | -0.81 |
| EBITDA
| 782.741 | 734.875 | 1,327.703 | 958.304 | 501.893 | 437.991 | 833.138 | 416.719 | 286.4 | 141.702 | 114.492 | 77.835 | 76.409 | 127.828 | 200.025 | 56.131 |
| EBITDA Ratio
| 0.191 | 0.173 | 0.225 | 0.19 | 0.124 | 0.114 | 0.184 | 0.125 | 0.103 | 0.182 | 0.13 | 0.095 | 0.102 | 0.155 | 0.219 | 0.118 |